GAMMA Investing LLC acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 1,472 shares of the company’s stock, valued at approximately $40,000.
A number of other institutional investors have also added to or reduced their stakes in the stock. Creative Financial Designs Inc. ADV grew its holdings in shares of Doximity by 16.7% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after purchasing an additional 473 shares in the last quarter. Neo Ivy Capital Management purchased a new position in shares of Doximity in the third quarter valued at $109,000. PNC Financial Services Group Inc. grew its holdings in shares of Doximity by 16.6% in the third quarter. PNC Financial Services Group Inc. now owns 6,500 shares of the company’s stock valued at $138,000 after purchasing an additional 925 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its holdings in shares of Doximity by 174.5% in the third quarter. Harel Insurance Investments & Financial Services Ltd. now owns 6,929 shares of the company’s stock valued at $146,000 after purchasing an additional 4,405 shares in the last quarter. Finally, Artemis Investment Management LLP purchased a new position in shares of Doximity in the fourth quarter valued at $228,000. 87.19% of the stock is owned by hedge funds and other institutional investors.
Doximity Trading Down 0.9 %
NASDAQ:DOCS opened at $24.09 on Friday. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $36.29. The company has a market cap of $4.49 billion, a price-to-earnings ratio of 36.50, a price-to-earnings-growth ratio of 3.06 and a beta of 1.18. The stock has a fifty day simple moving average of $26.45 and a 200-day simple moving average of $26.26.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on DOCS shares. SVB Leerink started coverage on shares of Doximity in a report on Monday, February 26th. They issued a “market perform” rating and a $32.00 target price for the company. Truist Financial raised their target price on shares of Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a report on Friday, February 9th. Wells Fargo & Company raised their target price on shares of Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, February 9th. Evercore ISI reaffirmed an “in-line” rating and set a $30.00 price objective on shares of Doximity in a research note on Tuesday, April 2nd. Finally, JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective for the company in a research note on Thursday, April 25th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $28.82.
Read Our Latest Report on DOCS
Insider Transactions at Doximity
In related news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $26.97, for a total value of $67,425.00. Following the completion of the sale, the director now directly owns 10,258 shares in the company, valued at $276,658.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 39.40% of the company’s stock.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
- Five stocks we like better than Doximity
- Business Services Stocks Investing
- MarketBeat Week in Review – 4/29 – 5/3
- How to Invest in Insurance Companies: A Guide
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is the Australian Securities Exchange (ASX)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.